A Strategy Towards 1,5-Dithio-1-enopyranosides
(413 mg, 95%). M.p. 62 °C, [α]2D0 = –249.0 (c = 0.9, CHCl3). 1H
NMR (250 MHz, CDCl3): δ = 5.98 (d, J = 4.2 Hz, 1 H, 2-H), 4.49
H, 5-H), 2.38 (s, 3 H, SCH3), 1.42 [s, 3 H, C(CH3)], 1.30 [s, 3 H,
C(CH3)] ppm. 13C NMR (63 MHz, CDCl3): δ = 131.8 (C-1), 122.4
(dd, J = 4.2, J = 5.7 Hz, 1 H, 3-H), 4.27 (ddd, J = 4.7, J = 5.7, J and 120.9 (C-8 and C-9), 117.2 (C-2), 112.2 and 111.1 (C-7 and C-
= 10.8 Hz, 1 H, 4-H), 2.79 (dd, J = 4.7, J = 12.4 Hz, 1 H, 5-H), 10), 107.8 [C(CH3)2], 73.4 (C-4), 71.8 (C-3), 36.6 (C-6), 31.5 (C-5),
2.70 (dd, J = 10.8, J = 12.4 Hz, 1 H, 5Ј-H), 2.37 (s, 3 H, SCH3), 28.5 and 25.4 [C(CH3)2], 17.1 (SCH3) ppm. MS (ESI): m/z = 296.1
1.47 [s, 3 H, C(CH3)], 1.38 [s, 3 H, C(CH3)] ppm. 13C NMR
[M – SO2CF3 + H]+. HRMS (ESI): calcd. for C14H18NO2S2 [M +
(63 MHz, CDCl3): δ = 138.1 (C-1), 116.8 (C-2), 107.4 [C(CH3)2], H]+ 296.0779; found 296.0783.
73.3 (C-4), 71.1 (C-3), 31.1 (C-5), 28.3 and 25.5 [2 C, C(CH3)2],
Methyl
2-Deoxy-3,4-O-isopropylidene-5-[methylepisulfonium]-1-
-erythro-pent-1-enopyranoside Trifluoromethanesulfonate Salt
16.5 (SCH3) ppm. MS (ESI): m/z = 219.0 [M + H]+, 241.0 [M +
Na]+, 257.0 [M + K]+. HRMS (ESI): calcd. for C9H14O2S2K [M +
K]+ 257.0072; found 257.0063.
thio-L
(18): 4-Picoline (150 µL, 1.55 mmol) was added to a solution of
ketene dithioacetal 9 (243 mg, 0.97 mmol) in dichloromethane
(12.2 mL). The mixture was cooled to –20 °C and trifluorometh-
anesulfonic anhydride was added dropwise (190 µL, 1.17 mmol).
The resulting mixture was stirred for 15 min at –20 °C and then
warmed up to 0 °C and stirred for 1 h. The crude product was
purified by flash chromatography over silica gel (dichloromethane/
methanol, 14:1). As described above, a small amount of pure sulfo-
nium 18 was isolated for characterization. Oil, [α]2D0 = +32.5 (c =
1.3, MeOH). 1H NMR (250 MHz, CD3OD): δ = 6.82 (d, J =
4.2 Hz, 1 H, 2-H), 4.91–4.81 (m, 2 H, 3-H and 4-H), 4.25 (dd, J =
12.9, J = 5.3 Hz, 1 H, 5-H), 3.99 (dd, J = 12.9, J = 2.0 Hz, 1 H,
5Ј-H), 3.22 (s, 3 H, S+CH3), 2.57 (s, 3 H, SCH3), 1.42 [s, 6 H,
C(CH3)2] ppm. 13C NMR (63 MHz, CD3OD): δ = 139.3 (C-2),
124.3 (C-1), 111.9 [C(CH3)2], 71.6 (C-3), 68.8 (C-4), 42.7 (C-5), 27.7
and 26.1 [2 C, C(CH3)2], 25.6 (S+CH3), 18.5 (SCH3) ppm. HRMS
(ESI): calcd. for C10H17O2S2 [M]+ 233.0670; found 233.0678.
Methyl 3,4-Di-O-benzyl-2-deoxy-1,5-dithio-D-threo-pent-1-enopyr-
anoside (14): Following the general procedure, 10 (1.64 mmol), 4-
picoline (620 µL, 6.38 mmol) and trifluoromethanesulfonic anhy-
dride (350 µL, 2.13 mmol) yielded 14 as a yellow oil (270 mg, 46%
over two steps). [α]2D0 = –164.5 (c = 0.9, CHCl3). 1H NMR
(500 MHz, CDCl3): δ = 7.28 (m, 10 H, 2ϫAr), 5.82 (d, J = 4.4 Hz,
1 H, 2-H), 4.68 (d, J = 12.0 Hz, 1 H, CH2Ph), 4.60 (s, 2 H, CH2Ph),
4.58 (d, J = 12.0 Hz, 1 H, CH2Ph), 4.01 (ddd, J = 0.6, J = 4.4, J
= 5.0 Hz, 1 H, 3-H), 3.95 (ddd, J = 2.4, J = 5.0, J = 7.3 Hz, 1 H,
4-H), 3.07 (dd, J = 2.4, J = 13.3 Hz, 1 H, 5-H), 3.00 (ddd, J = 0.6,
J = 7.3, J = 13.3 Hz, 1 H, 5Ј-H), 2.34 (s, 3 H, SCH3) ppm. 13C
NMR (126 MHz, CDCl3): δ = 138.5 and 138.1 (2 Cipso, Ar), 135.1
(C-1), 128.7–128.0 (10 CAr), 118.7 (C-2), 75.0 (C-3), 73.2 (C-4), 71.6
and 71.4 (2ϫCH2Ph), 29.4 (C-5), 17.1 (SCH3) ppm. MS (ESI): m/z
= 381.1 [M + Na]+, 397.1 [M + K]+. HRMS (ESI): calcd. for
C20H22O2NaS2 [M + Na]+ 381.0959; found 381.0963.
Supporting Information (see also the footnote on the first page of
1
this article): H and 13C NMR spectra for all new compounds.
Methyl 3,4,6-Tri-O-benzyl-2-deoxy-1,5-dithio-L-arabino-pent-1-eno-
pyranoside (15): Following the general procedure, 11 (273 mg,
0.54 mmol), 4-picoline (350 µL, 3.56 mmol) and trifluoromethane-
sulfonic anhydride (200 µL, 2.13 mmol) yielded 15 as a yellow oil
(222 mg, 86%). [α]2D0 = –143.0 (c = 1.0, CHCl3). 1H NMR
(250 MHz): δ = 7.23–7.17 (m, 15 H, 3ϫAr), 5.79 (dd, J = 0.7, J =
4.4 Hz, 1 H, 2-H), 4.60–4.38 (m, 6 H, 3ϫCH2Ph), 3.86–3.84 (m, 2
H, 3-H and 4-H), 3.65 (dd, J = 5.9, J = 8.8 Hz, 1 H, 6Ј-H), 3.59
(ddd, J = 2.0, J = 5.9, J = 7.3 Hz, 1 H, 5-H), 3.53 (dd, J = 7.3, J
= 8.8 Hz, 1 H, 6-H), 2.28 (s, 3 H, SCH3) ppm. 13C NMR (63 MHz,
CDCl3): δ = 138.2, 137.8 and 137.7 (3Cipso, Ar), 134.8 (C-1), 128.3–
127.6 (15 CAr), 117.4 (C-2), 73.0 (CH2Ph), 72.6 (C-4), 72.0 (C-3),
71.9 and 70.9 (2ϫCH2Ph), 68.3 (C-6), 43.0 (C-5), 16.8
(SCH3) ppm. MS (ESI): m/z = 501.4 [M + Na]+. HRMS (ESI):
calcd. for C28H30O3NaS2 [M + Na]+ 501.1534; found 501.1528.
Acknowledgments
The authors thank the Conseil Régional Champagne-Ardenne for
a doctoral fellowship (M. B.), and M. Gruit and V. Kikelj (under-
graduate students) for their participation in this work.
[1] J. G. Fernandez-Bolanos, N. A. L. Al-Masoudi, I. Maya, Adv.
Carbohydr. Chem. Biochem. 2001, 57, 21–98, and references
cited therein.
[2] R. J. Capon, J. K. MacLeod, J. Chem. Soc., Chem. Commun.
1987, 1200–1201.
[3] a) J. C. P. Schwarz, K. C. Yule, Proc. Chem. Soc. London 1961,
417; b) T. J. Adley, N. L. Owen, Proc. Chem. Soc. London 1961,
418.
Methyl 2-Deoxy-3,4-O-isopropylidene-6-O-trityl-1,5-dithio-L-ribo-
pent-1-enopyranoside (16): Following the general procedure, 12
(0.44 g, 0.85 mmol), 4-picoline (0.50 mL, 1.70 mmol) and trifluoro-
methanesulfonic anhydride (0.28 mL, 5.11 mmol) yielded 16 as an
oil (0.36 g, 87%). [α]2D0 = –48.4 (c = 0.8, CHCl3). 1H NMR
(250 MHz, CDCl3): δ = 7.58–7.50 (m, 5 H, Ar), 7.36–7.27 (m, 10
H, 2ϫAr), 5.83 (d, J = 4.0 Hz, 1 H, 2-H), 4.65 (dd, J = 4.0, J =
6.5 Hz, 1 H, 3-H), 4.54 (dd, J = 3.2, J = 6.5 Hz, 1 H, 4-H), 3.56–
3.49 (m, 1 H, 5-H), 3.31 (m, 2 H, 6-H), 2.42 (s, 3 H, SCH3), 1.38
[s, 3 H, C(CH3)], 1.26 [s, 3 H, C(CH3)] ppm. 13C NMR (63 MHz,
CDCl3): δ = 144.0 (Ar), 135.0 (C-1), 129.8–127.2 (15 CAr), 117.7
(C-2), 108.6 [C(CH3)2], 86.9 [C(Ar)3], 73.3 (C-4), 72.1 (C-3), 61.3
(C-6), 45.8 (C-5), 26.7 and 25.9 [C(CH3)2], 16.6 (SCH3) ppm. MS
[4] I. Robina, P. Vogel, Z. J. Witczak, Curr. Org. Chem. 2001, 5,
1177–1214, and references cited therein.
[5] Z. J. Witczak, J. M. Culhane, Appl. Microbiol. Biotechnol. 2005,
69, 237–244.
[6] F. Bellamy, V. Barberousse, N. Martin, P. Masson, J. Millet, S.
Samreth, C. Sepulchre, J. Theveniaux, D. Horton, Eur. J. Med.
Chem. 1995, 30, 101s–115s.
[7] a) M. Yoshikawa, T. Murakami, H. Shimada, H. Matsuda, J.
Yamahara, G. Tanabe, O. Murakoa, Tetrahedron Lett. 1997,
38, 8367–8370; b) M. Yoshikawa, T. Murakami, K. Yashiro,
H. Matsuda, Chem. Pharm. Bull. 1998, 46, 1339–1340; c) H.
Matsuda, T. Morikawa, M. Yoshikawa, Pure Appl. Chem. 2002,
74, 1301–1308.
[8] a) S. Mohan, B. M. Pinto, Carbohydr. Res. 2007, 342, 1551–
1580, and references cited therein; b) R. Nasi, L. Sim, D. R.
Rose, B. M. Pinto, J. Org. Chem. 2007, 72, 180–186; c) H. Liu,
R. Nasi, K. Jayakanthan, L. Sim, H. Heipel, D. R. Rose, B. M.
Pinto, J. Org. Chem. 2007, 72, 6562–6572.
(ESI): m/z
= 513.1 [M +
Na]+. HRMS (ESI): calcd. for
C29H30O3NaS2 [M + Na]+ 513.1534; found 513.1529.
Compound 17: Oil, [α]2D0 = –89.5 (c = 1.1, CHCl3). 1H NMR
(250 MHz, CDCl3): δ = 6.52 and 6.42 (2ϫd, J = 8.4 Hz, 2ϫ1 H,
8-H and 9-H), 5.12 and 4.94 (2ϫddd, J = 8.4, J = 3.6, J = 2.3 Hz,
2 H, 7-H and 10-H), 4.73 (br. s, 1 H, 6-H), 4.50 (d, J = 5.4 Hz, 1
H, 3-H), 4.21 (dt, J = 5.4, J = 3.8 Hz, 1 H, 4-H), 2.80–2.68 (m, 2
[9] W. Korytnyk, N. Angelino, O. Dodson-Simmons, M. Hanchak,
M. Madson, S. Valentekovic-Horvath, Carbohydr. Res. 1983,
113, 166–171.
Eur. J. Org. Chem. 2008, 3529–3534
© 2008 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
www.eurjoc.org
3533